{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:13:56Z","timestamp":1787066036282,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":20,"publisher":"Springer US","isbn-type":[{"value":"9781071644614","type":"print"},{"value":"9781071644621","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4462-1_17","type":"book-chapter","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T13:24:33Z","timestamp":1743686673000},"page":"229-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Elucidation of the Human Cerebrospinal Fluid Metabolome by Ion Mobility Mass Spectrometry and NMR Spectroscopy"],"prefix":"10.1007","author":[{"given":"Jannik","family":"Sprengel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgy","family":"Berezhnoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"12","key":"17_CR1","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1021\/pr9005876","volume":"8","author":"T Rosenling","year":"2009","unstructured":"Rosenling T, Slim CL, Christin C, Coulier L, Shi S, Stoop MP et al (2009) The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF). J Proteome Res 8(12):5511\u20135522. https:\/\/doi.org\/10.1021\/pr9005876","journal-title":"J Proteome Res"},{"issue":"6","key":"17_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/metabo10060251","volume":"10","author":"B Albrecht","year":"2020","unstructured":"Albrecht B, Voronina E, Schipke C, Peters O, Parr MK, D\u00edaz-Hern\u00e1ndez MD et al (2020) Pursuing experimental reproducibility: an efficient protocol for the preparation of cerebrospinal fluid samples for NMR-based metabolomics and analysis of sample degradation. Meta 10(6):251. https:\/\/doi.org\/10.3390\/metabo10060251","journal-title":"Meta"},{"issue":"9","key":"17_CR3","first-page":"811","volume":"12","author":"MV Fomenko","year":"2022","unstructured":"Fomenko MV, Yanshole LV, Tsentalovich YP (2022) Stability of metabolomic content during sample preparation: blood and brain tissues. Meta 12(9):811","journal-title":"Meta"},{"issue":"4","key":"17_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11306-018-1333-0","volume":"14","author":"MJ Noga","year":"2018","unstructured":"Noga MJ, Zielman R, van Dongen RM, Bos S, Harms A, Terwindt GM et al (2018) Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling. Metabolomics 14(4):44. https:\/\/doi.org\/10.1007\/s11306-018-1333-0","journal-title":"Metabolomics"},{"issue":"12","key":"17_CR5","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1373\/clinchem.2011.167601","volume":"57","author":"T Rosenling","year":"2011","unstructured":"Rosenling T, Stoop MP, Smolinska A, Muilwijk B, Coulier L, Shi S et al (2011) The impact of delayed storage on the measured proteome and metabolome of human cerebrospinal fluid. Clin Chem 57(12):1703\u20131711. https:\/\/doi.org\/10.1373\/clinchem.2011.167601","journal-title":"Clin Chem"},{"issue":"2","key":"17_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jchromb.2008.05.001","volume":"871","author":"DS Wishart","year":"2008","unstructured":"Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y et al (2008) The human cerebrospinal fluid metabolome. J Chromatogr B 871(2):164\u2013173. https:\/\/doi.org\/10.1016\/j.jchromb.2008.05.001","journal-title":"J Chromatogr B"},{"issue":"4","key":"17_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/17482960902871009","volume":"10","author":"A Wuolikainen","year":"2009","unstructured":"Wuolikainen A, Hedenstr\u00f6m M, Moritz T, Marklund SL, Antti H, Andersen PM (2009) Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS. Amyotroph Lateral Scler 10(4):229\u20132U8. https:\/\/doi.org\/10.1080\/17482960902871009","journal-title":"Amyotroph Lateral Scler"},{"issue":"2","key":"17_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11306-020-1648-5","volume":"16","author":"H Carlsson","year":"2020","unstructured":"Carlsson H, Abujrais S, Herman S, Khoonsari PE, \u00c5kerfeldt T, Svenningsson A et al (2020) Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry. Metabolomics 16(2):26. https:\/\/doi.org\/10.1007\/s11306-020-1648-5","journal-title":"Metabolomics"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3233\/JAD-142319","volume":"44","author":"T Koal","year":"2015","unstructured":"Koal T, Klavins K, Seppi D, Kemmler G, Humpel C (2015) Sphingomyelin SM(d18:1\/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-\u03b2 42, tau, and phospho-tau-181 levels. J Alzheimers Dis 44:1193\u20131201. https:\/\/doi.org\/10.3233\/JAD-142319","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"17_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/gm337","volume":"4","author":"R Mandal","year":"2012","unstructured":"Mandal R, Guo AC, Chaudhary KK, Liu P, Yallou FS, Dong E et al (2012) Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med 4(4):38. https:\/\/doi.org\/10.1186\/gm337","journal-title":"Genome Med"},{"issue":"50","key":"17_CR11","doi-asserted-by":"publisher","first-page":"18352","DOI":"10.1021\/acs.analchem.3c02900","volume":"95","author":"T Vallianatou","year":"2023","unstructured":"Vallianatou T, Nilsson A, Bj\u00e4rterot P, Shariatgorji R, Slijkhuis N, Aerts JT et al (2023) Rapid metabolic profiling of 1 \u03bcL crude cerebrospinal fluid by matrix-assisted laser desorption\/ionization mass spectrometry imaging can differentiate De Novo Parkinson\u2019s disease. Anal Chem 95(50):18352\u201318360. https:\/\/doi.org\/10.1021\/acs.analchem.3c02900","journal-title":"Anal Chem"},{"key":"17_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2024.117626","volume":"173","author":"D Xu","year":"2024","unstructured":"Xu D, Dai X, Zhang L, Cai Y, Chen K, Wu J et al (2024) Mass spectrometry for biomarkers, disease mechanisms, and drug development in cerebrospinal fluid metabolomics. TrAC Trends Anal Chem 173:117626. https:\/\/doi.org\/10.1016\/j.trac.2024.117626","journal-title":"TrAC Trends Anal Chem"},{"issue":"6","key":"17_CR13","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00216-012-6039-y","volume":"403","author":"D Vuckovic","year":"2012","unstructured":"Vuckovic D (2012) Current trends and challenges in sample preparation for global metabolomics using liquid chromatography\u2013mass spectrometry. Anal Bioanal Chem 403(6):1523\u20131548. https:\/\/doi.org\/10.1007\/s00216-012-6039-y","journal-title":"Anal Bioanal Chem"},{"issue":"10","key":"17_CR14","first-page":"236","volume":"9","author":"HA Haijes","year":"2019","unstructured":"Haijes HA, Willemse EAJ, Gerrits J, van der Flier WM, Teunissen CE, Verhoeven-Duif NM et al (2019) Assessing the pre-analytical stability of small-molecule metabolites in cerebrospinal fluid using direct-infusion metabolomics. Meta 9(10):236","journal-title":"Meta"},{"issue":"6","key":"17_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nprot.2010.50","volume":"5","author":"EJ Want","year":"2010","unstructured":"Want EJ, Wilson ID, Gika H, Theodoridis G, Plumb RS, Shockcor J et al (2010) Global metabolic profiling procedures for urine using UPLC\u2013MS. Nat Protoc 5(6):1005\u20131018. https:\/\/doi.org\/10.1038\/nprot.2010.50","journal-title":"Nat Protoc"},{"issue":"2","key":"17_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/brain\/awab320","volume":"145","author":"A Ntranos","year":"2021","unstructured":"Ntranos A, Park H-J, Wentling M, Tolstikov V, Amatruda M, Inbar B et al (2021) Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma. Brain 145(2):569\u2013583. https:\/\/doi.org\/10.1093\/brain\/awab320","journal-title":"Brain"},{"issue":"4","key":"17_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jimd.12213","volume":"43","author":"G Klinke","year":"2020","unstructured":"Klinke G, Richter S, Monostori P, Schmidt-Mader B, Garc\u00eda-Cazorla A, Artuch R et al (2020) Targeted cerebrospinal fluid analysis for inborn errors of metabolism on an LC-MS\/MS analysis platform. J Inherit Metab Dis 43(4):712\u2013725. https:\/\/doi.org\/10.1002\/jimd.12213","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"17_CR18","first-page":"126","volume":"11","author":"H Carlsson","year":"2021","unstructured":"Carlsson H, Rollborn N, Herman S, Freyhult E, Svenningsson A, Burman J et al (2021) Metabolomics of cerebrospinal fluid from healthy subjects reveal metabolites associated with ageing. Meta 11(2):126","journal-title":"Meta"},{"key":"17_CR19","doi-asserted-by":"publisher","unstructured":"Berezhnoy G, Laske C, Trautwein C (2023) Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer\u2019s disease patients. Front Aging Neurosci 15. https:\/\/doi.org\/10.3389\/fnagi.2023.1219718","DOI":"10.3389\/fnagi.2023.1219718"},{"key":"17_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100125","volume":"12","author":"JE Nielsen","year":"2021","unstructured":"Nielsen JE, Maltesen RG, Havelund JF, F\u00e6rgeman NJ, Gotfredsen CH, Vesterg\u00e5rd K et al (2021) Characterising Alzheimer's disease through integrative NMR- and LC-MS-based metabolomics. Metabol Open 12:100125. https:\/\/doi.org\/10.1016\/j.metop.2021.100125","journal-title":"Metabol Open"}],"container-title":["Methods in Molecular Biology","Cerebrospinal Fluid (CSF) Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4462-1_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:15:06Z","timestamp":1748596506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4462-1_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071644614","9781071644621"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4462-1_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"2 April 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}